NCT02843789View on ClinicalTrials.gov

Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Tocilizumab

Trial Locations (1)

Unknown

University Hospital, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02843789 - Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy | Biotech Hunter | Biotech Hunter